Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Nat Rev Dis Primers ; 2: 16028, 2016 05 12.
Article in English | MEDLINE | ID: mdl-27170253

ABSTRACT

Meniere's disease (MD) is a disorder of the inner ear that causes vertigo attacks, fluctuating hearing loss, tinnitus and aural fullness. The aetiology of MD is multifactorial. A characteristic sign of MD is endolymphatic hydrops (EH), a disorder in which excessive endolymph accumulates in the inner ear and causes damage to the ganglion cells. In most patients, the clinical symptoms of MD present after considerable accumulation of endolymph has occurred. However, some patients develop symptoms in the early stages of EH. The reason for the variability in the symptomatology is unknown and the relationship between EH and the clinical symptoms of MD requires further study. The diagnosis of MD is based on clinical symptoms but can be complemented with functional inner ear tests, including audiometry, vestibular-evoked myogenic potential testing, caloric testing, electrocochleography or head impulse tests. MRI has been optimized to directly visualize EH in the cochlea, vestibule and semicircular canals, and its use is shifting from the research setting to the clinic. The management of MD is mainly aimed at the relief of acute attacks of vertigo and the prevention of recurrent attacks. Therapeutic options are based on empirical evidence and include the management of risk factors and a conservative approach as the first line of treatment. When medical treatment is unable to suppress vertigo attacks, intratympanic gentamicin therapy or endolymphatic sac decompression surgery is usually considered. This Primer covers the pathophysiology, symptomatology, diagnosis, management, quality of life and prevention of MD.


Subject(s)
Meniere Disease/complications , Meniere Disease/physiopathology , Antiemetics/pharmacology , Antiemetics/therapeutic use , Audiometry/methods , Benzodiazepines/pharmacology , Benzodiazepines/therapeutic use , Catheter Ablation/methods , Dimenhydrinate/pharmacology , Dimenhydrinate/therapeutic use , Ear, Inner/pathology , Ear, Inner/physiopathology , Endolymph/metabolism , Ganglia, Sensory/abnormalities , Ganglia, Sensory/injuries , Hearing Loss/etiology , Humans , Magnetic Resonance Imaging/methods , Meclizine/pharmacology , Meclizine/therapeutic use , Meniere Disease/epidemiology , Promethazine/pharmacology , Promethazine/therapeutic use , Quality of Life/psychology , Tinnitus/etiology , Vertigo/etiology
2.
J Pediatr Surg ; 43(1): 222-6, 2008 Jan.
Article in English | MEDLINE | ID: mdl-18206486

ABSTRACT

The author describes an extremely rare case of coexistence with imperforate anus, malrotation, and double zonal aganglionosis. A colostomy was performed on a 2-day-old male infant at the proximal sigmoid colon, because the finding of an invertgram revealed an intermediate type of imperforate anus. At the age of 1 month, a distal colostogram showed the low type without fistula. An upper gastrointestinal series revealed malrotation. At 4 months of age, Ladd's procedure and an anoplasty were done. The function of the colostomy was not good. At laparotomy, a narrowing terminal ileum was removed for being a suspected intestinal obstruction. Histologic findings of the removed ileum revealed aganglionosis. A rectal suction biopsy showed the positive finding of acetyl cholinesterase staining. Therefore, the patient was diagnosed with extensive aganglionosis. At 9 months of age, a 1-stage ileoendorectal pull-through with a right colon onlay patch was performed. Histologically, a skipped ganglionic bowel segment at the right colon, a double zonal aganglionosis, was found among the extensive aganglionosis. Although the ganglionic right colon was used for the colon patch, which was placed for antiperistaltic movement, postoperatively the bowel function was excellent. The author herein describes an extremely rare case of coexistence of imperforate anus, intestinal malrotation, and double zonal Hirschsprung's disease. A case with this association, to the author's knowledge, has not been reported previously in the literature.


Subject(s)
Abnormalities, Multiple/diagnosis , Anus, Imperforate/diagnosis , Colon/innervation , Hirschsprung Disease/diagnosis , Intestinal Obstruction/diagnosis , Abnormalities, Multiple/surgery , Anus, Imperforate/surgery , Colon/abnormalities , Colostomy/methods , Combined Modality Therapy , Follow-Up Studies , Ganglia, Sensory/abnormalities , Hirschsprung Disease/surgery , Humans , Ileum/physiopathology , Ileum/surgery , Infant, Newborn , Intestinal Obstruction/surgery , Male , Rare Diseases , Risk Assessment
3.
Dev Neurosci ; 28(1-2): 92-101, 2006.
Article in English | MEDLINE | ID: mdl-16508307

ABSTRACT

The basic helix-loop-helix genes Hes1 and Hes5, known Notch effectors, regulate the maintenance of neural stem cells and the development of the central nervous system (CNS). In the absence of Hes1 and Hes5, the size, shape and cytoarchitecture of the CNS are severely disorganized, but the development of the peripheral nervous system remains to be analyzed. Here, we found that in Hes1;Hes5 double-mutant mice, the cranial and spinal nerve systems are also severely disorganized. In these mutant mice, axonal projections from the mesencephalic neurons to the trigeminal (V) ganglion become aberrant and the proximal parts of the glossopharyngeal (IX) and vagus (X) nerves are fused. The hypoglossal (XII) nerve is also formed poorly. Furthermore, the dorsal root ganglia are fused with the spinal cord, and the dorsal and ventral roots of the spinal nerves are lacking in many segments. These results indicate that Hes1 and Hes5 play an important role in the formation of the cranial and spinal nerve systems.


Subject(s)
Basic Helix-Loop-Helix Transcription Factors/genetics , Cranial Nerves/abnormalities , Gene Expression Regulation, Developmental/genetics , Homeodomain Proteins/genetics , Repressor Proteins/genetics , Spinal Nerves/abnormalities , Animals , Body Patterning/genetics , Cell Movement/genetics , Cranial Nerves/cytology , Ganglia, Autonomic/abnormalities , Ganglia, Autonomic/cytology , Ganglia, Sensory/abnormalities , Ganglia, Sensory/cytology , Ganglia, Spinal/abnormalities , Ganglia, Spinal/cytology , Mice , Mice, Knockout , Neural Crest/abnormalities , Neural Crest/cytology , Neural Pathways/abnormalities , Neural Pathways/cytology , Rhombencephalon/abnormalities , Rhombencephalon/cytology , Spinal Nerve Roots/abnormalities , Spinal Nerve Roots/cytology , Spinal Nerves/cytology , Transcription Factor HES-1
4.
Neuroscience ; 137(2): 531-6, 2006.
Article in English | MEDLINE | ID: mdl-16289886

ABSTRACT

The vagal and glossopharyngeal sensory ganglia and their peripheral tissues were examined in wild type and dystonia musculorum mice to assess the effect of dystonin loss of function on chemoreceptive neurons. In the mutant mouse, the number of vagal and glossopharyngeal sensory neurons was severely decreased (70% reduction) when compared with wild type littermates. The mutation also reduced the size of the circumvallate papilla (45% reduction) and the number of taste buds (89% reduction). In addition, immunohistochemical analysis demonstrated that the dystonin mutation reduced the number of PGP 9.5-, calcitonin gene-related peptide-, P2X3 receptor- and tyrosine hydroxylase-containing neurons. Their peripheral endings also decreased in the taste bud and epithelium of circumvallate papillae. These data together suggest that the survival of vagal and glossopharyngeal sensory neurons is dependent upon dystonin.


Subject(s)
Carrier Proteins/physiology , Cytoskeletal Proteins/physiology , Ganglia, Sensory/abnormalities , Glossopharyngeal Nerve/abnormalities , Nerve Tissue Proteins/physiology , Neurons, Afferent/metabolism , Vagus Nerve/abnormalities , Animals , Animals, Newborn , Calcitonin Gene-Related Peptide/metabolism , Carrier Proteins/genetics , Cell Differentiation/genetics , Cell Survival/genetics , Chemoreceptor Cells/abnormalities , Chemoreceptor Cells/metabolism , Chemoreceptor Cells/pathology , Cytoskeletal Proteins/genetics , Down-Regulation/genetics , Dystonin , Ganglia, Sensory/metabolism , Ganglia, Sensory/pathology , Glossopharyngeal Nerve/metabolism , Glossopharyngeal Nerve/pathology , Mice , Mice, Transgenic , Nerve Tissue Proteins/genetics , Neurons, Afferent/pathology , Nodose Ganglion/abnormalities , Nodose Ganglion/metabolism , Nodose Ganglion/pathology , Receptors, Purinergic P2/metabolism , Receptors, Purinergic P2X3 , Sensory Receptor Cells/abnormalities , Sensory Receptor Cells/metabolism , Sensory Receptor Cells/pathology , Taste/genetics , Taste Buds/abnormalities , Taste Buds/pathology , Tyrosine 3-Monooxygenase/metabolism , Ubiquitin Thiolesterase/metabolism , Vagus Nerve/metabolism , Vagus Nerve/pathology
5.
Neuron ; 20(3): 483-94, 1998 Mar.
Article in English | MEDLINE | ID: mdl-9539123

ABSTRACT

neurogenin2 encodes a neural-specific basic helix-loop-helix (bHLH) transcription factor related to the Drosophila proneural factor atonal. We show here that the murine ngn2 gene is essential for development of the epibranchial placode-derived cranial sensory ganglia. An ngn2 null mutation blocks the delamination of neuronal precursors from the placodes, the first morphological sign of differentiation in these lineages. Mutant placodal cells fail to express downstream bHLH differentiation factors and the Notch ligand Delta-like 1. These data suggest that ngn2 functions like the Drosophila proneural genes in the determination of neuronal fate in distal cranial ganglia. Interestingly, the homeobox gene Phox2a is activated independently of ngn2 in epibranchial placodes, suggesting that neuronal fate and neuronal subtype identity may be specified independently in cranial sensory ganglia.


Subject(s)
Ganglia, Sensory/embryology , Helix-Loop-Helix Motifs/physiology , Nerve Tissue Proteins/genetics , Neurons, Afferent/physiology , Animals , Basic Helix-Loop-Helix Transcription Factors , Cell Differentiation/physiology , Cell Lineage/genetics , Cranial Nerves/abnormalities , Cranial Nerves/cytology , Cranial Nerves/embryology , Female , Ganglia, Sensory/abnormalities , Ganglia, Sensory/cytology , Gene Expression Regulation, Developmental/physiology , Homeodomain Proteins/genetics , Mice , Mice, Mutant Strains , Motor Neurons/cytology , Motor Neurons/physiology , Mutagenesis/physiology , Nerve Tissue Proteins/metabolism , Neurons, Afferent/chemistry , Pregnancy , Somites/cytology , Stem Cells/chemistry , Stem Cells/physiology , Transcription Factors/genetics
6.
Neuron ; 18(3): 411-23, 1997 Mar.
Article in English | MEDLINE | ID: mdl-9115735

ABSTRACT

Phox2a is a vertebrate homeodomain protein expressed in subsets of differentiating neurons. Here, we show that it is essential for proper development of the locus coeruleus, a subset of sympathetic and parasympathetic ganglia and the VIIth, IXth, and Xth cranial sensory ganglia. In the sensory ganglia, we have identified two differentiation blocks in Phox2a-/- mice. First, the transient expression of dopamine-beta-hydroxylase in neuroblasts is abolished, providing evidence that Phox2a controls noradrenergic traits in vivo. Second, the expression of the GDNF receptor subunit Ret is dramatically reduced, and there is a massive increase in apoptosis of ganglion cells, which are known to depend on GDNF in vivo. Therefore, Phox2a appears to regulate conventional differentiation traits and the ability of neurons to respond to essential survival factors.


Subject(s)
Drosophila Proteins , Ganglia, Autonomic/abnormalities , Ganglia, Sensory/abnormalities , Homeodomain Proteins/physiology , Locus Coeruleus/abnormalities , Nerve Growth Factors , Nerve Tissue Proteins/physiology , Transcription Factors/physiology , Animals , Apoptosis , Cell Differentiation , Cranial Nerves/abnormalities , Cranial Nerves/embryology , Dopamine beta-Hydroxylase/biosynthesis , Embryonic and Fetal Development/genetics , Enzyme Induction , Female , Ganglia, Autonomic/embryology , Ganglia, Sensory/embryology , Glial Cell Line-Derived Neurotrophic Factor , Glial Cell Line-Derived Neurotrophic Factor Receptors , Homeodomain Proteins/genetics , Locus Coeruleus/embryology , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Morphogenesis/genetics , Nerve Tissue Proteins/biosynthesis , Nerve Tissue Proteins/deficiency , Nerve Tissue Proteins/genetics , Norepinephrine/physiology , Proto-Oncogene Proteins/biosynthesis , Proto-Oncogene Proteins c-ret , Receptor Protein-Tyrosine Kinases/biosynthesis , Recombinant Fusion Proteins/metabolism , Transcription Factors/deficiency , Transcription Factors/genetics , Transgenes
SELECTION OF CITATIONS
SEARCH DETAIL
...